University College London: CAR T Cell Therapy Targets Key Mutation Driving Rare Blood Cancers
July 02, 2026
July 02, 2026
LONDON, England, July 2 (TNSjou) -- The University College London posted the following news:
* * *
CAR T cell therapy targets key mutation driving rare blood cancers
A form of CAR T cell therapy can find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, in new research led by UCL and University of Oxford researchers.
MPNs a . . .
* * *
CAR T cell therapy targets key mutation driving rare blood cancers
A form of CAR T cell therapy can find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, in new research led by UCL and University of Oxford researchers.
MPNs a . . .